STOCK TITAN

Blake Borgeson to sell 220,000 RXRX (NASDAQ: RXRX) Class A shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

This Form 144 notice shows Blake C. Borgeson planning to sell up to 220,000 shares of the issuer’s Class A stock through Fidelity Brokerage Services on NASDAQ, with an aggregate market value of $924,000.

The filing also describes how these securities were acquired as founder shares from the issuer in two compensation grants of 110,000 Class A shares each on 09/01/2016 and 09/01/2017.

Over the past three months, Borgeson has already sold 220,000 Class A shares on 12/02/2025 for gross proceeds of $961,400 and another 220,000 shares on 01/06/2026 for $959,200.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filing for RXRX disclose about planned share sales?

The Form 144 discloses that Blake C. Borgeson plans to sell up to 220,000 Class A shares through Fidelity Brokerage Services on NASDAQ, with an indicated aggregate market value of about $924,000 for this planned transaction.

How many RXRX shares did Blake C. Borgeson sell in the last three months?

The filing shows Borgeson sold 220,000 Class A shares on 12/02/2025 for $961,400 and another 220,000 shares on 01/06/2026 for $959,200, totaling 440,000 shares sold in the last three months.

How were the RXRX shares in this Form 144 originally acquired?

The shares were acquired as founder shares directly from the issuer. The filing lists two compensation grants of 110,000 Class A shares each, dated 09/01/2016 and 09/01/2017, both identified as compensation rather than cash purchases.

What is the relationship between the planned RXRX sale and total shares outstanding?

The notice shows 220,000 Class A shares are planned for sale, while 514,895,802 shares of that class are outstanding. This provides context on the scale of the planned sale relative to the issuer’s overall Class A share base.

Which broker and exchange are involved in the planned RXRX share sale?

The planned sale of 220,000 Class A shares is listed as being placed through Fidelity Brokerage Services LLC, located in Smithfield, Rhode Island, with the securities identified for trading on the NASDAQ exchange.

On what approximate date are the RXRX shares in this Form 144 expected to be sold?

The document lists an approximate sale date of 02/03/2026 for the planned sale of 220,000 Class A shares. This date reflects when the filer expects to execute the transaction, subject to market conditions and applicable Rule 144 requirements.
Recursion Pharmaceuticals, Inc.

NASDAQ:RXRX

RXRX Rankings

RXRX Latest News

RXRX Latest SEC Filings

RXRX Stock Data

2.13B
493.81M
4.74%
69.3%
28.42%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
SALT LAKE CITY